Steffie Junius

[Cancer Discovery @CD_AACR]

The Immuno-oncology article collection highlights cutting-edge basic science discoveries, translational research advances, and clinical trials aimed at addressing these issues and expanding the reach of immuno-oncology. https://t.co/s4B6orhZPf

[Steffie Junius @steffiejunius]

@gerlanda_vella @EMBO @HUNIMED Congratulations! Well deserved!

[Emanuela Pasciuto @EmanuelaPasciu1]

PhD Position available @NIMlab_VIB
We offer a fully funded PhD position to study the role of T cells in Autism spectrum disorders. If you want to work in a dynamic and international environment @CMN_VIB in the beautiful city APPLY before 10th January

https://t.co/cBb2mKcVf8

[Adrian Liston @LabListon]

Amazing opportunity to join an exciting #neuroimmunology lab for a #PhD in Belgium. I highly recommend this opportunity!

[Nature Rev Immunol @NatRevImmunol]

A guide to thymic selection of T cells https://t.co/kF9EzkB2ZX

[Science Immunology @SciImmunology]

Researchers from @KU_Leuven @CBD_VIB demonstrated that plasticity is a property restricted to a limited subset of regulatory #Tcells. “Purging” this unstable subset could serve as an effective strategy to prevent this identity switch.

📄: https://t.co/J0vBcXneMg #WeekendReads

[T2EVOLVE @t2evolve_imi]

The @JanssenBelgium scientific symposium on Next-Generation Cell Therapy aims to provide a comprehensive understanding of the current state-of-the-art research in next-generation cell-based therapies.

Join @t2evolve_imi at the event by registering here:
https://t.co/17sfjnRvvN

[John Connolly @John_E_Connolly]

Single-cell mapping of combinatorial target antigens for CAR switches using logic gates | Nature Biotechnology #coolscience https://t.co/jxanAOTQzt

[The Abarca Prize @AbarcaPrize]

A recent study published in @scienceMagazine by @casanova_lab (award winner of I Edition), @aspaan1 and others, reveals that a rare autosomal dominant haploinsufficiency of #OTULIN impairs intrinsic cellular immunity to #staphylococcal alpha toxin.

https://t.co/HFv06R1m84

[Journal of Experimental Medicine @JExpMed]

.@CarlyEWhyte @singhkailash04 @labliston @jldvib et al identify a context-dependent hierarchy of #IL2 consumption & response. IL-2 sourced from different leukocytes drives different circuits of responding cells, independent of concentration https://t.co/Mm8vQiakwr #cytokines

[Carly Whyte @CarlyEWhyte]

Delighted to have the work from my post doc with @LabListon out in @JExpMed today! We show how the cellular context in which IL2 is expressed leads to vastly different outcomes:

https://t.co/isnFdoNczL

[Adrian Liston @LabListon]

Our latest work is out in @JExpMed! Work by @CarlyEWhyte, @singhkailash04, @jldvib and co on the context-dependent effects of the #IL2 network. One of the oldest and most important #cytokines and we are still learning news things about it! 1/17

https://t.co/SrwVd7cHOk

[Adrian Liston @LabListon]

The very talented @ys_lidia has her first last author paper, as she starts up her independent #neuroimmunology lab @KU_Leuven! Nice review on #brain #Tregs, with @jldvib

https://t.co/PyIF9Ob3BO

[Adrian Liston @LabListon]

Excited to share our new paper out at @NatImmunol today! We discovered the limiting factor for #brain #Tregs is #IL2, and developed a new #genetherapy to treat #traumaticbraininjury and other #neuroinflammatory pathologies. 1/12

https://t.co/EpDUyZnlOw

[Casanova Lab @casanova_lab]

1/ Today in @ScienceMagazine, @aspaan1 & colleagues show that human #OTULIN #haploinsufficiency impairs non-leukocytic cell-intrinsic immunity to the #staphylococcal alpha-toxin (https://t.co/Pagde6tPCJ).

[Adrian Liston @LabListon]

Hey there, #singlecell peeps, you ever use a #tSNE or #UMAP? It doesn't have to be just a pretty picture. We've developed statistical tests to compare multiple plots, calculate p values and the relative distance between multiple samples. 1/4

https://t.co/BMIcJXX9Gn

[Journal for ImmunoTherapy of Cancer @jitcancer]

Continue reading in this new #JITC review: Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside? https://t.co/F6Z4AOHzeT @EmmanuelDonnad1 @GuedanS

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC review: Time to evolve: predicting engineered T cell-associated toxicity with next-generation models https://t.co/nWOP6hfSwS @EmmanuelDonnad1 @GuedanS

[Cancer Cell @Cancer_Cell]

A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers https://t.co/Y4lg7ColU0

[Pedromics @pedromics]

"And what does that make you feel?"